GENE ONLINE|News &
Opinion
Blog

2018-05-02|

May 2, 2013: U.S. Research Team Published the First Genetic Test Predicting Surgery Efficacy

by GeneOnline
Share To

On May 2, 2013, the U.S. research team published a seven-year research report in the American Journal of Human Genetics, announcing the first genetic test to predict benefits of gastric bypass surgery, also known as Roux-en-Y gastric bypass (RYGB). The test results can be used to determine the long-term success rate of RYGB with up to 70% of accuracy. Discovery of the correlation between certain genes and the effect of RYGB stands for a strong evidence of how genetic factors influence patients’ response to surgery, and also represents a breakthrough in genetic technology on improving clinical medicne.

Reference
https://www.cell.com/ajhg/issue?pii=S0002-9297(13)X0006-0

Image Source
https://commons.wikimedia.org/wiki/File:Blausen_0776_Roux-En-Y_01.png

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
GeneOnline’s Weekly News Highlights: Aug 21-25
2023-08-28
BIO 2022: Addressing Bottlenecks in Gene Therapy
2022-08-03
R&D
Transcriptional Programs Uncovering the Genetic Causes of Psychiatric Disorders
2022-03-01
LATEST
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!
2024-04-16
Sequencing Revolution Spotlights the Titans of NGS Innovation
2024-04-16
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top